APA (7th ed.) Citation

Krasniqi, E., Filomeno, L., Arcuri, T., Di Lisa, F. S., Astone, A., Cutigni, C., . . . D'Angelo, T. (2024). Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study. Cancers, 16(23), 4104. https://doi.org/10.3390/cancers16234104

Chicago Style (17th ed.) Citation

Krasniqi, Eriseld, et al. "Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study." Cancers 16, no. 23 (2024): 4104. https://doi.org/10.3390/cancers16234104.

MLA (9th ed.) Citation

Krasniqi, Eriseld, et al. "Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study." Cancers, vol. 16, no. 23, 2024, p. 4104, https://doi.org/10.3390/cancers16234104.